Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications

Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications

Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products NEW YORK – Oct. 26, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that its portfolio company AXIM®...